Skip to main content
SpringerLink
Log in

Intracavernous alprostadil: effective therapy for erectile dysfunction

  • New Drugs and Therapeutics
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Montorsi F, Guazzoni G, Rigatti P, et al. Pharmacological management of erectile dysfunction. Drugs 1995 Sep; 50(3): 465–79

    Article  PubMed  CAS  Google Scholar 

  2. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachussetts Male Aging Study. J Urol 1994; 151: 54–61

    PubMed  CAS  Google Scholar 

  3. Lea AP, Bryson HM, Balfour JA. Intracavernous alprostadil: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction. Drug Aging 1996 Jan; 8(1): 56–74

    Article  CAS  Google Scholar 

  4. Lee LM, Stevenson RW, Szasz G. Prostaglandin El versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison. J Urol 1989 Mar; 141: 549–50

    PubMed  CAS  Google Scholar 

  5. Lui SM-C, Lin JS-N. Treatment of impotence: comparison between the efficacy and safety of intracavernous injection of papaverine plus phentolamine (regitine) and prostaglandin E1. Int J Impot Res 1990; 2 Suppl. 1: 147–57

    Google Scholar 

  6. Waldhauser M, Schramek P. Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction. J Urol 1988 Sep; 140: 525–7

    PubMed  CAS  Google Scholar 

  7. Roy JB, Petrone RL, Ibrahin T. A clinical trial of the intracorporal injection of papaverine/phentolamine vs PGE1 vs topical nitroglycerin ointment in the treatment of erectile dysfunction. Int J Impot Res 1990; 2 Suppl. 2: 305–6

    Google Scholar 

  8. Floth A, Schramek P. Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin El alone. J Urol 1991 Jan; 145: 56–9

    PubMed  CAS  Google Scholar 

  9. Shenfeld O, Hanani J, Shalhav A, et al. Papaverine-phentolamine and prostaglandin El versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study. J Urol 1995; 154(9): 1017–9

    PubMed  CAS  Google Scholar 

  10. Chen RN, Lakin MM, Montague DK, et al. Penile scarring with intracavernous injection therapy using prostaglandin E1: a risk factor analysis. J Urol 1996 Jan; 155: 138–40

    Article  PubMed  CAS  Google Scholar 

  11. Morley JE, Kaiser FE. Impotence in elderly men. Drug Aging 1992 Jul–Aug; 2(4): 330–44

    Article  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Intracavernous alprostadil: effective therapy for erectile dysfunction. Drugs Ther. Perspect 7, 1–5 (1996). https://doi.org/10.2165/00042310-199607060-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199607060-00001

Keywords

Search

Navigation